SOTK Q2 FY27 earnings call: key takeaways

• Sonotech reported revenue of $5.23 million for the second quarter of fiscal 2027, below the consensus estimate of $5.55 million (5:43)
• EPS was $0.02, below the consensus of $0.05

Results vs expectations

EPS basis: GAAP diluted EPS, SEC 10-Q

The stock moved -12.9% over the report window (S&P 500 ETF -1.1%). Earnings history

What changed since last quarter

• The company raised its outlook for fiscal 2028, citing increased visibility from large backlog orders. (8:59)
• The CEO emphasized the importance of systems integration capabilities, which have driven higher ASPs and margins. (21:29)
• The CFO noted that gross margin levels achieved in the first half may not be indicative of future periods due to variability in system shipments. (13:52)

What analysts pressed on

• Whether the shift to high-volume production systems will impact service and spare parts revenue. (50:27)
• How the company plans to manage increased capacity requirements as orders grow. (38:00)
• Concerns about the sustainability of current gross margin levels with the shift to larger, higher ASP systems. (46:22)

In their words

• The medical market continues to be seen customers increasingly move from process development to commercial manufacturing. (2:59)
• We are seeing increasing adoption of our technologies as customers move from development and qualification into commercial manufacturing. Steve Harshberger (5:43)
• These orders are from an existing customer that has successfully deployed Sonotech technology in an advanced clean energy manufacturing process. (8:59)
• We believe the increasing scale of these opportunities demonstrates the long-term potential of our technology and our customer relationships. (4:29)